Importantly, these findings, as documented by Wang et al. (2021) [77], provide valuable insights into SFN’s multifaceted role in suppressing GC cell growth and triggering apoptosis, thus highlighting its potential as a novel therapeutic agent for the treatment of gastric cancer. This evidence concerns the gene SFN and gastric cancer.